SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193805-14-002343
Filing Date
2014-12-04
Accepted
2014-12-04 13:34:02
Documents
1
Group Members
DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT, L.P.DEERFIELD PRIVATE DESIGN FUND II, L.P.DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e612962_sc13ga-dicerna.htm SC 13G/A 389150
  Complete submission text file 0001193805-14-002343.txt   390752
Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A

Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Subject) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87866 | Film No.: 141265872
SIC: 2834 Pharmaceutical Preparations